Part-Time
Copywriter
Brain Effect
51-200 employees
Nutritional supplements for mental performance
No salary listed
Berlin, Germany
Hybrid
Hybrid work with remote and office options.
 Growth & Marketing (1) |
|---|
Get referred to Brain Effect
See people who can refer or advise you
- At least 2 years of demonstrable experience in copywriting or direct-response copywriting, especially for Meta Ads, in e-commerce, direct-to-consumer, software as a service, or a performance-marketing agency.
- Deep understanding of sales psychology and conversion frameworks, including AIDA, Hook-Story-Offer, and objection handling in copy.
- Confident and skilled use of artificial-intelligence writing and productivity tools to continuously optimize workflows.
- German proficiency at C2 level and fluent English proficiency at B2 or C1 level.
- Ability to combine engaging storytelling with analysis of dashboard key performance indicators to identify what converts.
- Create high-impact ad copy, hooks, and headlines for Meta, Google, and other performance channels.
- Systematically create authentic scripts for user-generated-content creators and tailored briefings for influencer and podcast advertising formats.
- Implement and use artificial-intelligence prompts and workflows to test advertising-creative variations and significantly reduce creation time.
- Conceptualize, structure, and write core landing pages using sales psychology for conversion optimization.
- Analyze relevant data with the marketing team, derive clear insights, and continuously develop the copy.
BrainEffect designs nutritional supplements and functional foods to support mental and physical performance. Its products use science-backed formulations with natural ingredients across vitamins, minerals, prebiotics, probiotics, collagen, and proteins, with core items like FOCUS, SLEEP, and DAILY GUT that target sleep, gut health, focus, energy, and recovery. The brand sells online and through a broad retail network of 2,500+ stores including dm, Budni, and Amazon, and remains independently led by founder Fabian Foelsch after Schwabe Group’s investment and a two-thirds stake, combining Schwabe’s research capabilities with BrainEffect’s digital reach. The goal is to expand internationally with reliable, natural products that help people optimize mental performance and well-being in daily life and sports.
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Berlin, Germany
Founded
2015
Get referred to Brain Effect
See people who can refer or advise you
Simplify's Take
What believers are saying
- dm still lists multiple BrainEffect SKUs in March 2026, proving broad retail access.
- BrainEffect launched Recharge 3-in-1 Drink in May 2026, showing product innovation continues.
- Schwabe’s 2026 majority stake funds international expansion and lowers capital constraints.
What critics are saying
- Lebensmittelklarheit flagged unproven gut-health claims in April 2026, risking regulator scrutiny.
- Schwabe now controls two-thirds, so founder autonomy shrinks during the medium-term takeover.
- Amazon and dm commoditize supplements fast; BrainEffect’s premium pricing faces relentless margin pressure.
What makes Brain Effect unique
- Schwabe’s 2025 majority ownership gives BrainEffect pharmaceutical-grade quality and distribution leverage.
- BrainEffect sells sleep, focus, and gut products through DTC and dm.
- The brand still operates independently under founder Fabian Foelsch, preserving entrepreneurial speed.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Hybrid Work Options
Flexible Work Hours
401(k) Company Match
Mental Health Support
Employee Discounts
Growth & Insights and Company News
6 month growth
↑ 4%1 year growth
↑ 4%2 year growth
↑ 4%Karlsruhe, March 17, 2024 - The Schwabe Group, provider of natural health solutions, is acquiring a majority stake in the startup Braineffect and plans to take over the company completely in the medium term.
The Schwabe Group has acquired a majority stake in Braineffect, a Berlin-based dietary supplements brand, with plans for full acquisition. Braineffect will remain under founder Fabian Foelsch's leadership. The acquisition aligns with Schwabe's strategy to expand its digital health presence and direct-to-consumer approach. Braineffect, known for products like FOCUS and SLEEP, will focus on innovation and international growth, leveraging Schwabe's resources.
Berlin, 7. November 2020. Die internationale Wirtschaftskanzlei Osborne Clarke hat die Schwabe Gruppe bei einem Series-A Investment in BRAINEFFECT beraten. BRAINEFFECT will mit dem Kapital Innovation im Bereich Mind Nutrition & Brainfood weiter vorantreiben. Das neu eingeworbene Wachstumskapital soll vor allem für die Expansion innerhalb Europas, für eine Ausweitung des innovativen Produktportfolios und die Besetzung...
Patrick Kramer ist ein Bodyhacker, der selbst mehrere Implantate im Körper trägt. Im Gespräch mit dem brutkasten erklärt er das Potenzial für Biohacking-Startups.